“Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors”. 2026. SKIN The Journal of Cutaneous Medicine 10 (2): s728. https://doi.org/10.25251/wx06pe13.